Zacks Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-364	Closed	-$262K	–	691
2023 Q2	$262K	Sell	364 -33	-8%	-$25.4K	﹤0.01%	552
2023 Q1	$326K	Sell	397 -18	-4%	-$13.6K	﹤0.01%	505
2022 Q4	$299K	Sell	415 -141	-25%	-$104K	﹤0.01%	501
2022 Q3	$383K	Sell	556 -55	-9%	-$34.6K	0.01%	456
2022 Q2	$361K	Sell	611 -13,232	-96%	-$8.6M	0.01%	463
2022 Q1	$9.67M	Buy	13,843 +1,099	+9%	+$695K	0.13%	142
2021 Q4	$8.05M	Buy	12,744 +964	+8%	+$593K	0.11%	157
2021 Q3	$7.13M	Buy	11,780 +859	+8%	+$533K	0.11%	159
2021 Q2	$6.1M	Buy	10,921 +806	+8%	+$408K	0.1%	164
2021 Q1	$4.79M	Buy	+10,115	New	+$4.92M	0.09%	178
2018 Q4	–	Sell	-594	Closed	-$240K	–	574
2018 Q3	$240K	Buy	+594	New	+$226K	0.01%	482
2015 Q1	–	Sell	-1,203	Closed	-$494K	–	692
2014 Q4	$494K	Buy	+1,203	New	+$473K	0.02%	416